Singapore, July 17 -- Japan-based AstellasPharma Inc. has agreed on a Memorandum of Understanding (MoU) with the Korea Institute of Startup and Entrepreneurship Development (KISED), an umbrella organisation of the Ministry of SMEs and Startups, a Korean Government Agency, for the operation of the Partnership with Global Companies Programme, which aims to identify Korean drug-discovery startups and support their business growth and global expansion.

Under the terms of the MoU, KISED will provide overall management and research funding for the Partnership with Global Companies Programme. Astellas will provide Korean drug-discovery startups, which are selected together, with KISED with access to laboratory and office space at SakuLab-Tsukub...